ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Trump Budget “Blueprint”: 4 Ways It Will Impact Labs
...
Already a member? Log in here
FDA EUAs for Zika Tests
(As of March 15, 2017)
...
Already a member? Log in here
Emerging Markets: The Rapid Rise of Commercial Zika Diagnostics
...
Already a member? Log in here
Strategic Alliances Promote Test Access and Development
From - Laboratory Industry Report
In the early months of 2017, the diagnostic industry has seen several strategic alliances develop.
Among the most active companies…
Hologic Sells Blood Screening Business
From - Laboratory Industry Report
During a slow month for diagnostic M&A activity, a noteworthy deal was the closing of Grifols's acquisition of Hologic's blood screening business. The acquired assets include…
Revised Travel Ban Issued
From - Laboratory Industry Report
We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order…
Veracyte Announces Big Developments
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…